BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38492045)

  • 1. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining
    Feng L; Yang X; Wang C; Zhang H; Wang W; Yang J
    Pediatr Radiol; 2024 May; 54(5):805-819. PubMed ID: 38492045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of
    Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Optimal Radiomics Nomogram Based on
    Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.
    Feng L; Qian L; Yang S; Ren Q; Zhang S; Qin H; Wang W; Wang C; Zhang H; Yang J
    BMC Med Imaging; 2022 May; 22(1):102. PubMed ID: 35643445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An
    Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
    Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of early relapse and late relapse in intermediate- and high-risk neuroblastoma with an
    Feng L; Yao X; Lu X; Wang C; Wang W; Yang J
    Abdom Radiol (NY); 2024 Mar; 49(3):888-899. PubMed ID: 38315193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial Skeleton Radiomics of
    Feng L; Zhang S; Wang C; Li S; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 Nov; 30(11):2487-2496. PubMed ID: 36828720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive nomogram for lymph node metastasis and survival in gastric cancer using contrast-enhanced computed tomography-based radiomics: a retrospective study.
    Zhang W; Wang S; Dong Q; Chen W; Wang P; Zhu G; Chen X; Cai Y
    PeerJ; 2024; 12():e17111. PubMed ID: 38525272
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Feng L; Zhou Z; Liu J; Yao S; Wang C; Zhang H; Xiong P; Wang W; Yang J
    Acad Radiol; 2024 Mar; 31(3):1111-1121. PubMed ID: 37643929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification.
    Wu H; Wu C; Zheng H; Wang L; Guan W; Duan S; Wang D
    Eur Radiol; 2021 May; 31(5):3080-3089. PubMed ID: 33118047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
    Černý I; Prášek J; Kašpárková H
    Nuklearmedizin; 2016 Aug; 55(4):151-7. PubMed ID: 27054367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
    Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
    Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Wang P; Li T; Liu Z; Jin M; Su Y; Zhang J; Jing H; Zhuang H; Li F
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3097-3106. PubMed ID: 37160439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
    Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
    Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
    Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
    AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
    Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
    J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.